Literature DB >> 18312333

Scleromyxedema--thalidomide therapy.

A Martins, M J Paiva Lopes, R Tavares Belo, J C Rodrigues.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18312333     DOI： 10.1111/j.1468-3083.2007.02420.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

1.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

Review 2.  [Scleromyxedema].

Authors:  M Neufeld; C Sunderkötter; R K C Moritz
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

Review 3.  New insights on scleromyxedema.

Authors:  Laura Atzori; Caterina Ferreli; Franco Rongioletti
Journal:  J Scleroderma Relat Disord       Date:  2019-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.